|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trafficking and activity by immune cells are implicated in
the parturition process but little is known about the role
of macrophages in control of uterine contractility at
term. The present study tested the hypothesis that
endotoxin (lipopolysaccharide, LPS) enhances uterine
contractile activity through a mechanism that involves
activation of resident macrophages. Various uterotonins
and anti-inflammatory mediators were added to a standard
muscle bath preparation that contained strips of uterus
from day 15 pregnant C3H/HeN mice. Spontaneous and
agonist-induced contractile activity was enhanced
following LPS treatment. LPS increased amplitude but not
frequency of contractions. Addition of anti-inflammatory
cytokines, IL-10 or TGF
, to suppress macrophage
activation did not block LPS-induced increases in
contractility. By contrast, indomethacin given to block
prostaglandin production, suppressed the LPS-induced
increase in amplitude of contractions. Findings suggest
that an inflammatory response, possibly mediated by
activation of macrophage and prostaglandins, participates
in the regulation of amplitude, as opposed to frequency,
of contractile activity by the murine uterus before onset
of parturition.
This article has been cited by other articles:
![]() |
A. S.-Y. Leong, J. E. Norman, and R. Smith Vascular and Myometrial Changes in the Human Uterus at Term Reproductive Sciences, January 1, 2008; 15(1): 59 - 65. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |